M&A Firepower Report 2025
Life sciences M&A deal value fell 41% in 2024 to US$130b as biopharma integrated prior large acquisitions.
Company · UN · 1 documents
Life sciences M&A deal value fell 41% in 2024 to US$130b as biopharma integrated prior large acquisitions.